Przybylowski et al. reported elevated hepcidin and IL-6 levels in orthotopic heart transplant patients treated with mTOR inhibitors and suggested that chronic inflammation and increased hepcidin production may be responsible for functional iron deficiency in these patients (29). The gene discussed is MTOR; the disease is nutritional disorder.